<DOC>
	<DOCNO>NCT00249249</DOCNO>
	<brief_summary>The purpose study compare efficacy pitavastatin atorvastatin .</brief_summary>
	<brief_title>Study Compare Efficacy Pitavastatin With That Atorvastatin Lowering Cholesterol Levels</brief_title>
	<detailed_description>Following wash-out dietary lead-in period , patient receive either Atorvastatin Pitavastatin 12 week , order establish efficacy pitavastatin reduce cholesterol level .</detailed_description>
	<mesh_term>Hypercholesterolemia</mesh_term>
	<mesh_term>Dyslipidemias</mesh_term>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<mesh_term>Pitavastatin</mesh_term>
	<criteria>Males female ( age 1875 year ) . Nonpregnant , nonlactating female Women child bear potential use sustain contraceptive preparation approve mechanical contraceptive method . Eligible able participate give informed consent Must follow restrictive diet eat drink grapefruit Diagnosis primary hypercholesterolemia combine dyslipidemia Available every clinic visit , occur morning . Homozygous familial hypercholesterolemia familial hypoalphalipoproteinemia Conditions may cause secondary dyslipidemia . Condition might significantly alter absorption , distribution , metabolism , excretion drug . History pancreatic injury pancreatitis , impaired pancreatic function/injury Liver injury Impaired renal function Current obstruction urinary tract difficulty void due mechanical well inflammatory condition , likely require intervention course study regard clinically meaningful investigator Serum creatine kinase ( CK ) &gt; 5 x upper limit reference range ( ULRR ) . Uncontrolled hypothyroidism Severe acute illness severe trauma last 3 month Major surgery , 3 month prior Visit 1 Significant cardiovascular disease ( CVD ) prior randomization Evidence symptomatic heart failure , gross cardiac enlargement ; significant heart block cardiac arrhythmia . History uncontrolled complex ventricular arrhythmia , uncontrolled atrial fibrillation/flutter uncontrolled supraventricular tachycardia ventricular response rate &gt; 100 beat per minute rest . Left ventricular ( LV ) ejection fraction &lt; 0.25 History symptomatic cerebrovascular disease Conditions discretion investigator Known HIV infection Poorly control uncontrolled hypertension . Known muscular neuromuscular disease type Neoplastic disease Drug abuse continuous consumption 65 mL pure alcohol per day Exposure investigational new drug within 30 day study entry ingestion drug know toxic major organ system Current recent use supplement know alter lipid metabolism Hypersensitivity reaction HMGCoA reductase inhibitor Concomitant medication permit Resistant lipidlowering medication . Known hypersensitivity intolerance lipid lower agent Excessive obesity Regular clinic attendance morning impractical Signs mental dysfunction factor likely limit ability cooperate</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2010</verification_date>
	<keyword>hypercholesterolemia</keyword>
	<keyword>dyslipidemia</keyword>
	<keyword>kowa</keyword>
	<keyword>KRE</keyword>
	<keyword>pitavastatin</keyword>
	<keyword>NK-104</keyword>
</DOC>